Insights into the gut microbiota of Nigerian elderly with type 2 diabetes and non-diabetic elderly personsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers compared the gut microbiota of urban-dwelling Nigerian elderly people with type 2 diabetes (T2D) to healthy urban-dwelling elderly peers. This addressed a gap, since prior T2D microbiome research focused on Westernized populations.
How was it studied?
Whole microbial community DNA was extracted from stool samples of both groups. The V4 region of the 16S rRNA gene was Illumina-sequenced and analyzed in QIIME2, including predicted functional pathways.
What did they find?
Beta diversity differed significantly between groups, though alpha diversity did not. Ruminococcus (2.89% vs 2.21%), Collinsella (2.62% vs 1.25%), and Bifidobacteriaceae were enriched in the T2D group, while Clostridium (3.2% vs 5.6%) and Peptostreptococcaceae (1.99% vs 3.45%) were enriched in healthy volunteers. Amino acid biosynthesis pathways rose in T2D, while respiration and building-block biosynthesis pathways rose in healthy volunteers.
Why it matters?
This is the first African elderly cohort showing Bifidobacteriaceae, Collinsella, and Ruminococcus abundance track with T2D status. The authors suggest restoring microbiota features linked to healthiness could help improve elderly patient care.